Pipeline — registered trials by phase
No registered trials in this stage.
No registered trials in this stage.
A Study to Assess the Safety, Tolerability and Efficacy of RG2417 in Bipolar I Depression
— · Bipolar I Depression · Completed · est. 2010-12
Phase II Study to Assess RG2417 in the Treatment of Bipolar I Depression
— · Bipolar Depression · Completed
Safety and Efficacy of Synthetic Human Secretin-Enhanced MRCP in Subjects With Abnormalities of the Pancreas
— · Pancreatitis · Completed · est. 2009-10
Synthetic Human Secretin in Children With Autism
— · Autism · Completed
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Repligen is lead sponsor; 4 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- SCHEDULE 13G/A2026-10-07SCHEDULE 13G/A
- 8-K2026-10-06Current report (material event)
- 4252026-09-30425
- 8-K2026-09-15Current report (material event)
- 4252026-09-08425
- 8-K2026-09-08Current report (material event)
- EFFECT2026-09-04EFFECT
- 424B32026-09-04424B3
- S-4/A2026-09-04S-4/A
- S-42026-08-25S-4
- SCHEDULE 13G/A2026-08-14SCHEDULE 13G/A
- 4252026-08-04425
- SCHEDULE 13G2026-07-31SCHEDULE 13G
- 10-Q2026-07-29Quarterly report
- 8-K2026-07-28Current report (material event)
- 4252026-07-24425
- 4252026-07-22425
- 4252026-07-22425
- 8-K2026-07-22Current report (material event)
- 8-K2026-05-15Current report (material event)
- 10-Q2026-05-06Quarterly report
- 8-K2026-05-05Current report (material event)
- DEFA14A2026-04-27DEFA14A
- ARS2026-04-02Annual report to holders
- DEFA14A2026-04-02DEFA14A
- DEF 14A2026-04-02Proxy statement
- SCHEDULE 13G/A2026-03-27SCHEDULE 13G/A
- 10-K2026-02-26Annual report
- 8-K2026-02-24Current report (material event)
- SCHEDULE 13G/A2026-02-17SCHEDULE 13G/A
- SCHEDULE 13G/A2026-02-13SCHEDULE 13G/A
- SCHEDULE 13G2026-02-05SCHEDULE 13G
- 8-K2026-01-06Current report (material event)
- 10-Q2025-11-04Quarterly report
- 8-K2025-10-28Current report (material event)
- UPLOAD2025-09-10UPLOAD
- SCHEDULE 13G/A2025-09-08SCHEDULE 13G/A
- 8-K2025-09-02Current report (material event)
- CORRESP2025-08-26CORRESP
- UPLOAD2025-08-14UPLOAD
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.